Stéphane Chauvie

10PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Ecosystem services (incl. pollination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 14, 2025
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Rexhep Durmo, Stephane Chauvie, Carla Minoia

|May 13, 2025
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

|Oct 27, 2023
A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation.

Stephane Chauvie, Lorenzo Nicola Mazzoni, Jim O'Doherty

|Dec 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.

Alberto Biggi, Stephane Chauvie, Federico Fallanca

Pageof 2

Frequent Collaborators

4 joint publications

Antonio Pinto

3 joint publications

Jacopo Olivieri

2 joint publications

Armando Santoro

2 joint publications

Luca Guerra